Table 7 |
|||||||||||
|
Outcome comparisons in effect sizes: Sensitivity analyses (SA) |
|||||||||||
|
Analysis |
Median |
Interquartile range |
Ranges: Number (percentage) of comparisons |
N (total) |
N |
||||||
|
|
|||||||||||
|
≤ -0.8 |
-0.79 to -0.5 |
-0.49 to -0.2 |
-0.19 to 0.19 |
0.2 to 0.49 |
0.5 to 0.79 |
≥ 0.8 |
Comparisons |
Cohorts |
|||
|
|
|||||||||||
|
Main analysis: any design, setting, intervention, and baseline status |
0.11 |
-0.11 to 0.35 |
13 (3) |
20 (4) |
58 (11) |
214 (41) |
142 (27) |
53 (10) |
17 (3) |
517 (100) |
84 |
|
SA1: Design: only observational studies (excluding randomised controlled trials) |
0.08 |
-0.14 to 0.28 |
6 (2) |
11 (4) |
40 (13) |
140 (47) |
77 (26) |
21 (7) |
6 (2) |
301 (100) |
44 |
|
SA2: Setting: only primary care/health maintenance organization |
0.24 |
0.03 to 0.38 |
3 (2) |
4 (3) |
9 (7) |
42 (30) |
60 (43) |
16 (12) |
4 (3) |
138 (100) |
27 |
|
SA3: Intervention: only drugs, physiotherapy, other physical therapy, or mixed |
0.08 |
-0.09 to 0.30 |
3 (1) |
7 (2) |
36 (11) |
164 (50) |
86 (26) |
21 (6) |
8 (2) |
325 (100) |
49 |
|
SA4: Baseline status: only comparisons with small baseline difference (< 0.50 standard deviation) |
0.08 |
-0.13 to 0.28 |
5 (1) |
14 (4) |
41 (12) |
161(47) |
81 (24) |
29 (9) |
9 (3) |
340 (100) |
81 |
|
SA1 + SA2 + SA3 + SA4 |
0.07 |
-0.03 to 0.19 |
0 (0) |
0 (0) |
2 (13) |
10 (63) |
3 (19) |
0 (0) |
1 (6) |
16 (100) |
5 |
|
|
|||||||||||
|
Hamre et al. BMC Medical Research Methodology 2008 8:11 doi:10.1186/1471-2288-8-11 |
|||||||||||
